 <h1>Ergomar Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ergotamine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ergotamine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Ergomar.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ergotamine: oral tablets, rectal suppositories, sublingual tablets</i></p><h3>Warning</h3><p><ul>
<li>
Possible serious and/or life-threatening cerebral and/or peripheral ischemia when used concomitantly with potent CYP3A4 inhibitors (see Interactions); concomitant use contraindicated.&lt;sup&gt;138&lt;/sup&gt; &lt;sup&gt;139&lt;/sup&gt; &lt;sup&gt;140&lt;/sup&gt;</li></ul></p><ul>
<li>
Possible serious and/or life-threatening cerebral and/or peripheral ischemia when used concomitantly with potent CYP3A4 inhibitors (see Interactions); concomitant use contraindicated.&lt;sup&gt;138&lt;/sup&gt; &lt;sup&gt;139&lt;/sup&gt; &lt;sup&gt;140&lt;/sup&gt;</li></ul><p></p><p>Side effects include:</p><p>Nausea, vomiting, abdominal pain, numbness and tingling of the fingers and toes, muscle pain in the extremities, weakness in the legs.    </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ergotamine: compounding powder, sublingual tablet</i></p><h3>General</h3><p>The most commonly reported adverse effects have included nausea and vomiting.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Serious vasoconstrictive have occurred, more commonly with long-term therapy at relatively high doses, however, they have been reported with short-term or normal doses.</p><h3>Nervous system</h3><p>Reports of cerebral ischemia, including 1 death, have been reported for patients receiving ergotamine (the active ingredient contained in Ergomar) and protease inhibitors concomitantly.  A black box warning is now required labeling for these drugs.</p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Ischemia, cyanosis, absence of pulse, cold extremities, precordial distress, EKG changes, gangrene, transient tachycardia, bradycardia, hypertension</p><h3>Nervous system</h3><p><b>Rare</b> (less than 0.1%): Cerebral ischemia</p><p><b>Frequency not reported</b>: Paresthesias, numbness, weakness</p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Nausea, vomiting</p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Musculoskeletal aches, pains, and cramps</p><h3>Other</h3><p><b>Frequency not reported</b>: Vertigo</p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Localized edema, itching</p><p id="ref_1">1. "Product Information. Ergomar (ergotamine)." Rosedale Therapeutics, Bristol, TN. </p><h2>More about Ergomar (ergotamine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>1 Review</li>
<li>Drug class: antimigraine agents</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Migraine</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>